| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print June 27, 2002
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00107.2002
Submitted on April 10, 2002
Accepted on June 11, 2002
1 Bone Marrow Transplantation Department, Hadassah University Hospital, Jerusalem, Israel
2 Department of Pulmonary, Boston University School of Medicine, Boston, MA, USA
3 Bone Marrow Transplantation Department, Hadassah University Hospital, Jerusalem, Israel; Department of Pulmonary, Boston University School of Medicine, Boston, MA, USA; Department of Pulmonary, Boston University School of Medicine, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: rgoldstein{at}lung.bumc.bu.edu.
The role of IL-4 in the development of lung fibrosis is as yet unclear. Bleomycin (Bleo) or saline (Sal) was injected intratracheally into 3 groups of C57Bl/6J mice: transgenic animals that overexpressed IL-4 (IL-4 TG) (n = 14), mice with a targeted knockout mutation of the IL-4 gene (IL-4 KO) (n = 11), and wild-type (WILD) (n = 13) mice. At 14 days, lung fibrosis was evaluated by hydroxyproline measurement and by quantitative image analysis of fibrosis fraction and alveolar wall area fraction. BAL cell counts in all Bleo-treated groups demonstrated an increased percentage of lymphocytes with a corresponding decrease in the percentage of macrophages. Comparing Bleo- to Sal-treated controls within each group of mice showed increases in all lung fibrosis parameters in IL-4 KO and WILD, but not in any of the parameters in IL-4 TG mice. The severity of Bleo-induced fibrotic response was decreased in overexpressed IL-4 TG compared with IL-4 KO mice. These data negate a critical pro-fibrotic role for IL-4 in Bleo-induced lung fibrosis.
This article has been cited by other articles:
|
|
 |
|
  P. Misson, F. Brombacher, M. Delos, D. Lison, and F. Huaux Type 2 immune response associated with silicosis is not instrumental in the development of the disease Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L107 - L113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Beamer and A. Holian Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L186 - L195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arora, Y. Hernandez, J. R. Erb-Downward, R. A. McDonald, G. B. Toews, and G. B. Huffnagle Role of IFN-{gamma} in Regulating T2 Immunity and the Development of Alternatively Activated Macrophages during Allergic Bronchopulmonary Mycosis J. Immunol., May 15, 2005; 174(10): 6346 - 6356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cavarra, F. Carraro, S. Fineschi, A. Naldini, B. Bartalesi, A. Pucci, and G. Lungarella Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1186 - L1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cisneros-Lira, M. Gaxiola, C. Ramos, M. Selman, and A. Pardo Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L949 - L956. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
